Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2014 March;53(1) > Minerva Pneumologica 2014 March;53(1):43-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PNEUMOLOGICA

A Journal on Diseases of the Respiratory System


Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index


eTOC

 

CASE REPORTS  


Minerva Pneumologica 2014 March;53(1):43-5

language: English

Hepatotoxicity due to montelukast: a case-based review of literature

Sargin G. 1, Coskun A. 2, Yavasoglu I. 3, Yasa M. H. 2

1 Department of Internal Medicine Adnan Menderes University Medical Faculty Aydin, Turkey;
2 Division of Gastroenterology Adnan Menderes University Medical Faculty Aydin, Turkey;
3 Division of Hematology Adnan Menderes University Medical Faculty Aydın, Turkey


PDF  


Montelukast is a selective antagonist of cysteinyl leukotriene receptors. Drug-induced hepatotoxicity and abnormal levels of serum aminotransferases may be detected in patients without any clinical symptoms. In literature, several side effects about montelukast have been reported with clinical sings such as jaundice etc. with elevated bilirubin levels. Here, we report 60-year-old female patient who had a medical history about montelukast receiving and elevated serum aminotransferases without any clinical sings.

top of page

Publication History

Cite this article as

Corresponding author e-mail